National HIV/AIDS Strategy for the United States: Updated to 2020

In July 2015, the White House released the National HIV/AIDS Strategy for the United States: Updated to 2020. This Update reflects the work accomplished and the new scientific developments since 2010 and charts a course for collective action across the Federal government and all sectors of society to move us close to the Strategy’s vision. […]

L.A. Trans* Health Summit: Creating Comprehensive Services for the Trans* Community

On June 30, 2015, the Los Angeles County Commission on HIV Transgender Caucus hosted a one-day event entitled, “L.A. Trans* Health Summit: Creating Comprehensive Services for the Trans* Community.” The purpose of the event was to bring together consumers, community members, and service providers to explore the health and HIV needs of the transgender community […]

Young South African Women Can Adhere to Daily PrEP Regimen as HIV Prevention, Study Finds

A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection—an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept […]

Stephanie Kovalchik, Ph.D. – Scaled Inverse Probability Weighting for Event Non-Reporting in Ecological Momentary Assessment Studies

Slide presentation: Scaled Inverse Probability Weighting for Event Non-Reporting in Ecological Momentary Assessment Studies Ecological momentary assessment (EMA) is an increasingly popular assessment method in the behavioral sciences that aims to capture events, emotions, and cognitions in real time, usually repeatedly throughout the day. Because EMA typically involves more intensive monitoring than traditional assessment methods, […]

Dr. Yvonne Bryson MD – Progress and Strategies for HIV remission and Cure

CURE overview June 2015 Yvonne Bryson MD Distinguished Professor and Chief Global Pediatric Infectious Disease DGSOM at UCLA, Mattel Children’s  

HIV Prevalence Rates, Risk Factors and Health Disparities Among Transgender Persons

The Los Angeles County Commission on HIV and the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) invite you to attend “HIV Prevalence Rates, Risk Factors and Health Disparities Among Transgender Persons” on Thursday, July 9, 2015 at 9:30am at St. Anne’s Maternity Home.

LA Pride

This past weekend, as part of an initiative to educate people about Pre-Exposure Prophylaxis (PrEP) for HIV prevention, Christopher Street West Association (CSW) partnered with a diverse group of HIV/AIDS and LGBT organizations to participate in LA Pride. Palm cards with information about PrEP were distributed to parade attendants and a PrEP pavilion was set […]

HIV Prevention Trials Network (HPTN) Annual Meeting

On Tuesday, June 16, 2015, Drs. Steve Shoptaw and Raphy Landovitz, from the CHIPTS Combination Prevention Core, delivered well-received plenaries at the HIV Prevention Trials Network (HPTN) Annual Meeting in Washington, DC.  Dr. Shoptaw presented early in the order with a brief but comprehensive presentation on the topic of “Non-Injection Substance Use and HIV.” Dr. […]

Romas Geleziunas, PhD – Strategies to Achieve ART-free HIV Remission: An Industry Perspective

Romas Geleziunas, PhD Director, Clinical Virology Gilead Sciences, Inc. “Strategies to Achieve ART-free HIV Remission: An Industry Perspective.” Grand Rounds This monthly lecture series, which is offered by the UCLA CFAR / AIDS Institute, consists of hour-long lunchtime lectures, delivered by invited guests or distinguished members of the Institute faculty, on a broad range of […]

Jacob Konikoff – Cross-Sectional HIV Incidence Estimation: Approaches and Challenges

Jacob Konikoff, Ph.D. candidate Department of Biostatistics UCLA Fielding School of Public Health Abstract: Tracking and surveillance of the HIV epidemic depend on accurate estimation of the number of new infections in the population. The rate at which these infections occur, known as the incidence, is also critical for effectively designing, targeting, and evaluating prevention […]